GlassScriptPhysician profile
Deepinder Singh Osahan
NPI 1649597063
$3,943.03
in general payments reported to CMS, 2019-2025
18 companies · $1,340 in 2025
The $1,340 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $231 · 2021: $523 · 2022: $215 · 2023: $684 · 2024: $82.46 · 2025: $1,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,105.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,368.11 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $625.00 | 2019-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $479.40 | 2019-2021 | |
| Genzyme Corporation | $461.55 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $226.06 | 2019-2025 | Dupixent |
| Advanced Respiratory, INC | $143.05 | 2020-2021 | |
| Electromed, INC. | $140.27 | 2021-2025 | Smartvest |
| Horizon Therapeutics Plc | $125.00 | 2023 | Uplizna |
| Inspire Medical Systems, INC. | $119.99 | 2025 | Inspire |
| Baxter Healthcare | $43.98 | 2023 | Hillrom - Monarch Airway Clearance System |
| Insmed, INC. | $37.84 | 2020-2024 | Arikayce |
| Circassia INC. | $36.32 | 2019 | |
| Shionogi INC | $29.65 | 2022 | |
| Axsome Therapeutics, INC. | $28.20 | 2023 | Sunosi |
| Shire North American Group INC | $22.25 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $20.43 | 2025 | Zepbound |
| Grifols USA, LLC | $18.75 | 2022 | |
| Amgen INC. | $17.18 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepinder Osahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.